MAIN CONTENT
When fear of falling changed the priorities
For years, Ng balanced a career with raising three children while paying less attention to her own well-being. Weight gain during perimenopause brought her to 69 kilograms at a height of 163 centimetres by December 2023. Yet it was feeling unsteady at 52, and worrying about falling, that made the future suddenly tangible. Strength and independence mattered more than an ideal number on the scales.
She was diagnosed with type 2 diabetes in June 2023, received medication to control blood sugar and started daily insulin that December. In September 2024 her doctors prescribed Ozempic, which acts on the GLP-1 pathway. The account published by the South China Morning Post says it reduced her appetite and helped her approach dietary change. The excerpt provided, however, contains no laboratory series or complete medication history with which readers could independently establish remission.
Nutrition and muscle, rather than a miracle formula
Her story matters because it shifts attention from rapid weight loss toward practices that may be sustained. Food quality, suitable portions and regular physical activity are established components of type 2 diabetes management.















